Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Busy address KBO
61 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Brussels Medical Device Center from Anderlecht, company number BE0663935801, closed financial year 2025 with a result of € -204,457 after tax. For that financial year Brussels Medical Device Center recorded a gross margin of € -59,763 and equity of € 217,020. Compared with financial year 2024, the result moved from € -798,986 to € -204,457. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on October 7, 2026.
€ 217,020
▼ 49% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -204,457
▲ 74 % less loss than in 2024
Profit after tax over the fiscal year.
€ 140,631
▼ 66% vs 2024
Cash and bank balances on the last day of the fiscal year.
People and assets in 2025
2
▼ 3.2 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 110,977
▼ 81% vs 2024
€ 55,500 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 2,762
▼ 59% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 1,750
▼ 96% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 165
▼ € 36,992 vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 560,783 | € 345,705 | € -200,790 | € -59,763 | ▲ € 141,027 |
| Profit after taxes | € -2,405 | € -126,613 | € -798,986 | € -204,457 | ▲ € 594,529 |
| Equity | € 1,358,589 | € 1,226,739 | € 422,584 | € 217,020 | ▼ 49% |
| Total debts | € 108,745 | € 71,816 | € 79,413 | € 1,915 | ▼ 98% |
| Cash | € 1,368,479 | € 895,228 | € 408,221 | € 140,631 | ▼ 66% |
| Retained profit | € 1,345,448 | € 1,218,834 | € 419,848 | € 215,391 | ▼ 49% |
| Balance sheet total | € 1,467,335 | € 1,298,555 | € 501,997 | € 218,935 | ▼ 56% |
| Employees (FTE) | 6.3 | 4.5 | 5.2 | 2 | ▼ 3.2 |
Key figures of Brussels Medical Device Center, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Brussels Medical Device Center?
What happened at Brussels Medical Device Center in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 204,457. filed late Source: NBB ↗
- Nicolas CAUCHE became a director. NBB
- Alain DELCHAMBRE became a director. NBB
- Jacques DEVIERE became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 2,405 loss in 2022 to € 204,457 loss in 2025.
Paid € 5,316 in corporate taxes since 2022.
On average € 76,800 of value added per employee in 2023.
Management
Behind Brussels Medical Device Center are Nicolas CAUCHE, Alain DELCHAMBRE and Jacques DEVIERE. Alain DELCHAMBRE is also behind ASSOCIATION VINCOTTE NUCLEAR and PÔLE MECA TECH. Jacques DEVIERE is also behind GASTRO - ENTEROLOGIE ET ENDOTHERAPIE, GIPHIC and Centre d'innovation médicale Michel Cremer/Marie Curie.
Directors
According to the 2025 annual accounts
Nicolas CAUCHE
Managing director
since 2023
since 2023
Jacques DEVIERE
Vice-chairman of the board
Also active at: GASTRO - ENTEROLOGIE ET ENDOTHERAPIE, GIPHIC, Centre d'innovation médicale Michel Cremer/Marie Curie
since 2023
Establishments
Establishment units
Physical locations of this company
Researchdreef 12
1070 Anderlecht
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 61 companies are registered at this address.
All companies at this address →Vereniging van Frabrikanten en Invoerders van wetenschappelijke Medische en Controleapparaten
€ 678,657 revenue · 2025
CYRILLUS BENELUX
€ 1.9 million revenue · 2025
BATICOOL
€ 336,834 gross margin · 2024
EEBIC
€ 669,567 gross margin · 2025
TRIANGLE SOLUTIONS RH
€ 30.1 million revenue · 2025
+56 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0663.935.801
- VAT number
- BE 0663.935.801
- Registered office
- Researchdreef 12, 1070 Anderlecht
- Names & denominations
- Brussels Medical Device Center · BMDC
- Enterprise type
- Rechtspersoon
- Legal form
- Non-profit association
- Legal situation
- Normale toestand
- Start date
- 7 October 2016
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied